BioXcel (BTAI) EBITDA margin US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | -42 012% | -12 030% | -7 783% | |||||
Changes by years, y/y, % | +29 982pp | -71.4% |
BioXcel. EBITDA margin, %
BioXcel. EBITDA margin, changes, pp
BioXcel (BTAI) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EBITDA margin, % | ? | -23 995% | -10 979% | -12 608% | -5 226% | -4 098% | -7 783% | |
Changes by years, y/y, % | +15 852pp | +16 575pp | +19 897pp | |||||
Changes by quarters, q/q, % | -2 193pp | +13 015pp | -1 628pp | +7 382pp | +1 128pp |